A Premarket, Prospective, Randomized, Single-Blind Study to Compare the Veriset™ Hemostatic Patch to TachoSil® as an Adjunct to Hemostasis in Subjects Undergoing Cardiovascular Surgery

NCT01639833 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Cardiac Surgical Procedures
Hemorrhage

Interventions

DEVICE: Veriset Hemostatic Patch
DEVICE: TachoSil®

Sponsor

Medtronic - MITG